{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:21:28Z","timestamp":1793762488880,"version":"4.6.1"},"reference-count":28,"publisher":"Wiley","issue":"21-22","license":[{"start":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T00:00:00Z","timestamp":1471392000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Academic Research fund of Hoseo University"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Nursing"],"published-print":{"date-parts":[[2016,11]]},"abstract":"<jats:sec><jats:title>Aims and objectives<\/jats:title><jats:p>The objective was to survey the current state of human papillomavirus (<jats:styled-content style=\"fixed-case\">HPV<\/jats:styled-content>) vaccination and the predictors of vaccination intention among Korean male students of high school (ages 15\u201319) and university (ages 17\u201327).<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Human papillomavirus is a sexually transmitted infectious agent causing uterine cervical, anal, and\/or penile cancer and genital warts in males and females. Infection rate of human papillomavirus increases from the age when sexual intercourse first occurs. Therefore, motivation to receive human papillomavirus vaccination is needed to protect infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Cross\u2010sectional descriptive survey was performed only in male students. They are less aware of human papillomavirus than females, because human papillomavirus vaccination has been targeted on females for preventing cervical cancer in Korea.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were collected using a self\u2010reporting questionnaire for male high school and university students sampled from a city in Korea. Human papillomavirus vaccine\u2010related knowledge, health beliefs, demographic, and sexual history information variables relating to intentions to vaccinate were assessed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The human papillomavirus vaccination rate was very low and the levels of knowledge and health beliefs were low. The significant predictors that raised the intention of human papillomavirus vaccination were a university student, experience of sexual intercourse and perceiving the benefits of human papillomavirus vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>To promote human papillomavirus vaccination, educational programming targeting males should include health beliefs and knowledge, emphasising that vaccination is important to prevent uterine cervical cancer and to role as a preventative measure against common male diseases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Relevance to clinical practice<\/jats:title><jats:p>Male high school students should be included as a major target population for school human papillomavirus education programmes, as they are at the age of commencing sexual intercourse. In addition, public health policies including human papillomavirus vaccination in the national immunisation programme are warranted.<\/jats:p><\/jats:sec>","DOI":"10.1111\/jocn.13461","type":"journal-article","created":{"date-parts":[[2016,7,5]],"date-time":"2016-07-05T14:20:45Z","timestamp":1467728445000},"page":"3354-3362","source":"Crossref","is-referenced-by-count":15,"title":["A study on the predictors of Korean male students' intention to receive human papillomavirus vaccination"],"prefix":"10.1111","volume":"25","author":[{"given":"Jeong Sil","family":"Choi","sequence":"first","affiliation":[{"name":"College of Nursing Gachon University Yeonsu\u2010dong Yeonsu\u2010gu Incheon Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seungmi","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Nursing Hoseo University Baebang, Asan, Chungnam Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,17]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.005"},{"key":"e_1_2_9_3_1","unstructured":"Australian Government Department of Health(2016)National Immunization Program Schedule. Available at:http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/national-immunisation-program-schedule."},{"key":"e_1_2_9_4_1","first-page":"630","article-title":"FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunizatio\u0171n Practices (ACIP)","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_9_5_1","first-page":"1705","article-title":"Recommendations on the use of quadrivalent human papillomavirus vaccine in males \u2013 Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_9_6_1","first-page":"1117","article-title":"National and state vaccination coverage among adolescents aged 13 through 17\u00a0years \u2013 United States, 2010","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"Morbidity and\u00a0Mortality Weekly Report"},{"key":"e_1_2_9_7_1","first-page":"69","article-title":"CDC Grand rounds: reducing the burden of HPV\u2010associated cancer and disease","volume":"63","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","journal-title":"Morbidity and Mortality Weekly Report"},{"key":"e_1_2_9_8_1","unstructured":"Centers for Disease Control and Prevention (CDC)(2016)HPV (Human Papillomavirus) Gardasil\u00ae\u20109 VIS. Available at:http:\/\/www.cdc.gov\/vaccines\/hcp\/vis\/vis-statements\/hpv-gardasil-9.html(accessed 12 June 2016)."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpag.2007.12.007"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.3758\/BF03193146"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23764"},{"key":"e_1_2_9_12_1","first-page":"1090","article-title":"Knowledge regarding cervical cancer, human papillomavirus and future acceptance of vaccination among girls in their late teens in Korea","volume":"50","author":"Han YJ","year":"2007","journal-title":"Korean Journal of Obstetrics & Gynecology"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1258\/095646203321605486"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.040"},{"key":"e_1_2_9_15_1","unstructured":"Korea Food and Drug Administration (KFDA)(2011)Gardasil. Available at:http:\/\/medication.kfda.go.kr\/main\/index.jsp(accessed 14 June 2015)."},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.5388\/jkon.2011.11.1.65"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.3200\/JACH.53.5.225-230"},{"key":"e_1_2_9_18_1","unstructured":"National Health Service (NHS)(2014)NHS Choices: Childhood Vaccine Timeline. Available at:http:\/\/www.nhs.uk\/Conditions\/vaccinations\/Pages\/childhood-vaccination-schedule.aspx(accessed 10 June 2016)."},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.4069\/kjwhn.2011.17.4.346"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.7739\/jkafn.2012.19.2.201"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.02.101"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181bf542c"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.06.114"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.06.020"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1086\/421279"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.08.045"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00038-009-0072-4"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2009.10.002"},{"key":"e_1_2_9_29_1","unstructured":"World Health Organization (WHO)(2015)Human papillomavirus (HPV) and Cervical Cancer. WHO Fact sheets. Available at:http:\/\/www.who.int\/mediacentre\/factsheets\/fs380\/en\/(accessed 8 May 2016)."}],"container-title":["Journal of Clinical Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjocn.13461","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjocn.13461","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jocn.13461","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T23:22:03Z","timestamp":1696202523000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jocn.13461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,17]]},"references-count":28,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1111\/jocn.13461"],"URL":"https:\/\/doi.org\/10.1111\/jocn.13461","archive":["Portico"],"relation":{},"ISSN":["0962-1067","1365-2702"],"issn-type":[{"value":"0962-1067","type":"print"},{"value":"1365-2702","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,17]]}}}